While in agreement to your comments - and those of procrastinator and lakota6 - I shall be on record for the following:
- There will not be a CR on the back of the results for BTX1308's phase 1.
- As psoriasis and Atopic Dermatatis are both T-cell mediated inflammatory diseases of the skin, successful data from that trial bodes well for BTX1204's phase 2.
- BTX1503's trial is currently at "recruitment peak" so it's still a bit early for sp movements on 'visual' basis.
-If BTX1503's trial data is good, that's a game changer and any future CR will be done at a premium.
Patience is a tricky beast to ride.
Bot Chart, page-385
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.3¢ |
Change
0.008(2.38%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 32.5¢ | 31.0¢ | $624.4K | 1.958M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 440962 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 515755 | 15 |
View Market Depth
| Last trade - 13.40pm 22/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
